Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2018

Dec 18, 2018

34975_dirs_2018-12-18_b863ec4c-e06a-4b70-a408-b9fe46a78d52.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2018-12-14

Reporting Person: KENNEDY JOHN F (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-12-14 Common Stock G 47687 $0.00 Disposed 262793 Direct

Footnotes

F1: This transaction involved gifts of securities by the reporting person. Purchase price is not applicable as these transactions were bona fide gifts.

F2: Includes (a) a deferred stock award of 800 restricted stock units which vest on December 31, 2018; (b) a deferred stock award of 18,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2018, immediately prior to the commencement of such meeting, and (ii) May 17, 2019; (c) a deferred stock award of 3,475 restricted stock units which vest on December 31, 2018; and (d) 240,418 shares of common stock held by the Reporting Person.